1 |
Bełtowski J. Short-term follow-up BNP level and risk stratification after myocardial infarction. International Journal of Cardiology 2019;291:173-4. [DOI: 10.1016/j.ijcard.2019.05.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
2 |
Shen J, Liu G, Yang Y, Li X, Zhu Y, Xiang Z, Gan H, Huang B, Luo S. Prognostic impact of mean heart rate by Holter monitoring on long-term outcome in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Clin Res Cardiol 2021;110:1439-49. [PMID: 33547959 DOI: 10.1007/s00392-021-01806-1] [Reference Citation Analysis]
|
3 |
Almeida I, Chin J, Santos H, Miranda H, Santos M, Sá C, Almeida S, Sousa C, Almeida L. Prognostic value of brain natriuretic peptide in ST-elevation myocardial infarction patients: A Portuguese registry. Revista Portuguesa de Cardiologia 2021. [DOI: 10.1016/j.repc.2020.12.016] [Reference Citation Analysis]
|
4 |
Qin Z, Du Y, Zhou Q, Lu X, Luo L, Zhang Z, Guo N, Ge L. NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study. Cardiol Res Pract 2021;2021:9943668. [PMID: 34765262 DOI: 10.1155/2021/9943668] [Reference Citation Analysis]
|